S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
NASDAQ:MYMD

MyMD Pharmaceuticals - MYMD Stock Forecast, Price & News

$3.00
-0.14 (-4.46%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.85
$3.23
50-Day Range
$2.22
$5.80
52-Week Range
$1.88
$9.95
Volume
98,995 shs
Average Volume
160,653 shs
Market Capitalization
$114.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MYMD stock logo

About MyMD Pharmaceuticals (NASDAQ:MYMD) Stock

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Receive MYMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MYMD Stock News Headlines

MyMD Pharmaceuticals (MYMD) and The Competition Head to Head Analysis
Comparing MyMD Pharmaceuticals (MYMD) & Its Rivals
Comparing MyMD Pharmaceuticals (MYMD) and Its Competitors
Healthcare & Pharmaceuticals
MyMD Pharmaceuticals, Inc. (MYMD)
See More Headlines
Receive MYMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MYMD Company Calendar

Last Earnings
8/15/2022
Today
10/05/2022
Next Earnings (Estimated)
11/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MYMD
Employees
6
Year Founded
N/A

Profitability

Net Income
$-29,890,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.58 million
Book Value
$0.62 per share

Miscellaneous

Free Float
33,769,000
Market Cap
$114.17 million
Optionable
Not Optionable
Beta
1.44

Key Executives

  • Dr. Christopher C. Chapman Jr. (Age 69)
    M.D., Pres, Chief Medical Officer & Director
    Comp: $286.54k
  • Mr. Paul  Rivard Esq.Mr. Paul Rivard Esq. (Age 51)
    Exec. VP of Operations & Gen. Counsel
    Comp: $225k
  • Dr. Adam Kaplin M.D. (Age 54)
    Ph.D., Chief Scientific Officer
    Comp: $376.72k
  • Mr. Ian Rhodes CPA (Age 49)
    Interim Chief Financial Officer













MYMD Stock - Frequently Asked Questions

How have MYMD shares performed in 2022?

MyMD Pharmaceuticals' stock was trading at $6.06 on January 1st, 2022. Since then, MYMD shares have decreased by 52.5% and is now trading at $2.88.
View the best growth stocks for 2022 here
.

When is MyMD Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our MYMD earnings forecast
.

How were MyMD Pharmaceuticals' earnings last quarter?

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) released its earnings results on Monday, August, 15th. The company reported ($0.09) earnings per share for the quarter.

What is MyMD Pharmaceuticals' stock symbol?

MyMD Pharmaceuticals trades on the NASDAQ under the ticker symbol "MYMD."

How do I buy shares of MyMD Pharmaceuticals?

Shares of MYMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MyMD Pharmaceuticals' stock price today?

One share of MYMD stock can currently be purchased for approximately $2.88.

How much money does MyMD Pharmaceuticals make?

MyMD Pharmaceuticals (NASDAQ:MYMD) has a market capitalization of $109.61 million and generates $1.58 million in revenue each year. The company earns $-29,890,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis.

How can I contact MyMD Pharmaceuticals?

MyMD Pharmaceuticals' mailing address is 855 N. WOLFE STREET, BALTIMORE MD, 21205. The official website for the company is www.mymd.com. The company can be reached via phone at 856-848-8698, via email at investors@akersbio.com, or via fax at 856-848-0269.

This page (NASDAQ:MYMD) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.